Stay updated on Vemurafenib+Cobimetinib Beyond Progression in BRAF+ Melanoma Clinical Trial
Sign up to get notified when there's something new on the Vemurafenib+Cobimetinib Beyond Progression in BRAF+ Melanoma Clinical Trial page.

Latest updates to the Vemurafenib+Cobimetinib Beyond Progression in BRAF+ Melanoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3, indicating a minor version bump on the page. This change does not modify the page content or study details.SummaryDifference0.0%

- Check24 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2, indicating a newer release of the page's content/markup. This change is internal and does not modify the study details or eligibility information.SummaryDifference0.0%

- Check38 days agoChange DetectedNew navigation and help items were added (How to Read a Study Record, Common Questions, How to Join a Study) and the study-record area now includes Last verified and Last known status was. The page revision tag has been updated from Revision: v3.5.5 to Revision: v3.6.0 to reflect the updated template.SummaryDifference1%

- Check45 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5 on the page, signaling an internal update to the study record. This change does not alter the study details, eligibility criteria, locations, or outcomes displayed to users.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision: v3.5.4 was added and the previous Revision: v3.5.3 was removed, reflecting an update to the page's revision history.SummaryDifference0.0%

- Check87 days agoChange DetectedThe page’s interface/display revision was updated from **v3.5.2** to **v3.5.3**, indicating a site version change rather than a change to the underlying study information.SummaryDifference0.0%

Stay in the know with updates to Vemurafenib+Cobimetinib Beyond Progression in BRAF+ Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vemurafenib+Cobimetinib Beyond Progression in BRAF+ Melanoma Clinical Trial page.